Publication | Closed Access

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients1Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Angeles, U.S.A.1

Endocrine OncologyBreast OncologyMay 1998MedicineClinical TrialsGynecologyAmerican SocietyBreast CancerMenopausePharmacotherapyMenopause Hormone TherapyEndocrinologyOncologyRadiation OncologyLos AngelesEndocrine-related CancerWomen's HealthHealth Sciences